Literature DB >> 24502125

Assessment of exposure of workers to ionizing radiation from radioiodine and technetium in nuclear medicine departmental facilities.

Grazyna Krajewska1, Krzysztof A Pachocki2.   

Abstract

BACKGROUND: Due to its use of ionising radiation, the field of nuclear medicine is a unique and significant part of medical diagnostics and patient treatment. The aim of this study was to assess the internal exposure of nuclear medicine employees to radioiodine 131I and technetium 99mTc as well as to assess the external exposure doses.
MATERIAL AND METHODS: The radioiodine 131I and technetium 99mTc contents in the thyroid of staff members (about 100 persons) dealing with these radionuclides have been measured in four departments of nuclear medicine. The measurements were conducted with a portable detection unit for in situ measurements of radioiodine and technetium. High sensitivity environmental thermoluminescent dosimeters (TLD) were used to measure the external exposure dose.
RESULTS: The average values and ranges of radioiodine 131I activity measured in the thyroids of all of the medical units' employees were: 83 Bq (range: 70-250 Bq), 280 Bq (range: 70-4000 Bq), 275 Bq (range: 70-1000 Bq) for technical staff, nuclear medicine staff and hospital services staff, respectively. The mean value of technetium 99mTc content in the thyroids of nuclear medicine staff was approximately 1500 Bq (range: 50--1800 Bq). External exposure dose rates were in the range of 0.5-10 microGy/h.
CONCLUSIONS: The calculated average effective dose for particular person caused by the inhalation of radioiodine 131I is below 5% of 20 mSv/year (occupational exposure limit).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24502125     DOI: 10.13075/mp.5893.2013.0061

Source DB:  PubMed          Journal:  Med Pr        ISSN: 0465-5893            Impact factor:   0.760


  7 in total

1.  99mTc activity concentrations in room air and resulting internal contamination of medical personnel during ventilation-perfusion lung scans.

Authors:  K Brudecki; E Borkowska; K Gorzkiewicz; M Kostkiewicz; T Mróz
Journal:  Radiat Environ Biophys       Date:  2019-04-17       Impact factor: 1.925

2.  Genotoxicity Associated with 131I and 99mTc Exposure in Nuclear Medicine Staff: A Physical and Biological Monitoring Study.

Authors:  Justyna Miszczyk; Aleksander Gałaś; Agnieszka Panek; Aldona Kowalska; Magdalena Kostkiewicz; Eliza Borkowska; Kamil Brudecki
Journal:  Cells       Date:  2022-05-16       Impact factor: 7.666

3.  Assessment of Residual Radioactivity by a Comprehensive Wireless, Wearable Device in Thyroid Cancer Patients Undergoing Radionuclide Therapy and Comparison With the Results of a Home Device: A Feasibility Study.

Authors:  R Gallicchio; D Scapicchio; A Nardelli; T Pellegrino; M Prisco; P Mainenti; C Sirignano; P Pedicini; G Storto
Journal:  IEEE J Transl Eng Health Med       Date:  2020-12-02       Impact factor: 3.316

4.  Retrospective Biological Dosimetry at Low and High Doses of Radiation and Radioiodine Impact on Individual Susceptibility to Ionizing Radiation.

Authors:  Antonina Cebulska-Wasilewska; Mateusz Krzysiek; Grażyna Krajewska; Artur Stępień; Paweł Krajewski
Journal:  Genome Integr       Date:  2017-01-23

5.  Measurement of 131I activity in thyroid of nuclear medical staff and internal dose assessment in a Polish nuclear medical hospital.

Authors:  K Brudecki; A Kowalska; P Zagrodzki; A Szczodry; T Mroz; P Janowski; J W Mietelski
Journal:  Radiat Environ Biophys       Date:  2016-12-31       Impact factor: 1.925

6.  Occupational exposure and radiobiological risk from thyroid radioiodine therapy in Saudi Arabia.

Authors:  H I Al-Mohammed; A Sulieman; Fareed H Mayhoub; Hassan Salah; Celestino Lagarde; M Alkhorayef; Ali Aldhebaib; C Kappas; D A Bradley
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

7.  Necessity of Internal Monitoring for Nuclear Medicine Staff in a Large Specialized Chinese Hospital.

Authors:  Hong-Bo Wang; Qing-Zhao Zhang; Zhen Zhang; Chang-Song Hou; Wen-Liang Li; Hui Yang; Quan-Fu Sun
Journal:  Int J Environ Res Public Health       Date:  2016-04-12       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.